En Ben Su
Chief Executive Officer bei GETEIN BIOTECH, INC
Vermögen: 284 Mio $ am 30.04.2024
Profil
En Ben Su is the founder of Getein Biotech, Inc. which was founded in 2002.
He held the title of Chairman & General Manager starting in 2014.
Currently, Dr. Su is the Chairman at Wuhan King Diagnostic Technology Co., Ltd.
since 2020 and Chairman at Jiangsu China Railway Arit New Materials Co., Ltd.
since 2018.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
GETEIN BIOTECH, INC. CLASS A
43,23% | 26.05.2023 | 219 218 114 ( 43,23% ) | 284 Mio $ | 30.04.2024 |
Aktive Positionen von En Ben Su
Unternehmen | Position | Beginn |
---|---|---|
GETEIN BIOTECH, INC | Chief Executive Officer | 20.11.2014 |
Jiangsu China Railway Arit New Materials Co., Ltd.
Jiangsu China Railway Arit New Materials Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Jiangsu China Railway Arit New Materials Co. Ltd. provides research and development services. The company is located in China. | Chairman | 01.09.2018 |
Wuhan King Diagnostic Technology Co., Ltd.
Wuhan King Diagnostic Technology Co., Ltd. Medical SpecialtiesHealth Technology Wuhan King Diagnostic Technology Co., Ltd. engages in the research and development of vitro diagnostic instruments and vitro diagnostic reagents. The company was founded by Quan Xin Ma on March 16, 2006 and is headquartered in Wuhan, China. | Chairman | 28.08.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GETEIN BIOTECH, INC | Health Technology |
Health Technology |
Private Unternehmen | 1 |
---|---|
Jiangsu China Railway Arit New Materials Co., Ltd.
Jiangsu China Railway Arit New Materials Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Jiangsu China Railway Arit New Materials Co. Ltd. provides research and development services. The company is located in China. | Commercial Services |